跳至主要内容
临床试验/NCT02331524
NCT02331524已完成不适用

Exercise and Psychosocial-Based Interventions to Improve Daily Activity in Heart Failure

Grand Valley State University2 个研究点 分布在 1 个国家目标入组 16 人开始时间: 2014年10月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
16
试验地点
2
主要终点
Change in Medtronic Implanted Device Patient Activity Measure

研究概览

简要总结

There are few studies that demonstrate how to best improve daily activity in people with heart failure (HF). Exercise alone has been shown to be ineffective, but other techniques such as daily activity feedback with encouragement or health coaching may be helpful. This research study will investigate two different treatment approaches for improving daily activity: 1) daily activity feedback and encouragement, and 2) health coaching with an individualized home exercise program. Both treatment approaches are hypothesized to result in improved daily activity compared to a control group.

详细描述

Few studies have been able to demonstrate intervention efficacy for improving daily activity in heart failure (HF). Exercise alone is ineffective, though psychosocial-based interventions including health coaching and daily activity feedback appear to be promising. Therefore, the primary purpose of the present proposed study is to investigate the effect of two different intervention approaches (1. daily activity feedback with associated encouragement, and 2. health coaching with an associated individualized home exercise program) on daily activity, exercise tolerance, HF-related health status, and lower extremity functional strength. A secondary purpose is to compare daily activity as recorded by Medtronic® implanted cardioverter defibrillator (ICDs) and cardiac resynchronization therapy (CRT) devices to daily activity recorded by a well-established triaxial accelerometer.

This will be a single-blinded randomized trial, with subject randomization stratified by age and baseline activity level. Subjects will be randomized to one of three groups: 1) A control group receiving usual care, 2) a group receiving only feedback with associated encouragement about their daily activity, and 3) an intervention group that will receive health coaching with an associated individualized home exercise program.

The study will consist of a 3 month intervention period and a 6 month follow-up/ retention period (total study enrollment period of 9 months). The primary study endpoint is Medtronic device-measured daily activity. All study endpoints will be assessed at baseline, 3 months, and 9 months. The investigators who are conducting study measurements will be blinded to group assignment.

Using a previously established minimum clinically important difference (MCID) of 1.08 hours per day for improvement in daily activity (effect size=1.54) as measured by Medtronic ICDs/CRTs, a total of 8 subjects per group would be needed to achieve a statistical power (1-β) of 0.80 (two-tailed, α=0.05) for a between-groups comparison utilizing two groups. Therefore, depending on the observed effect size in the proposed study, utilizing 3 groups with approximately 10 subjects in each group should provide adequate statistical power for a between-groups comparison with 3 groups.

Statistical analyses will be conducted to meet the planned study objectives. With regard to intervention effects, one way analysis of variance with planned contrasts will be used to examine between-group differences for each of the continuous variables [Patient Activity, Kansas City Cardiomyopathy Questionnaire (KCCQ), Patient Health Questionnaire (PHQ-9), six-minute walk test (6MWT), 30 second timed chair rise (30-s TCR), heart rate variability, Optivol Fluid Index]. If the data do not meet the requisite assumptions, the Kruskal-Wallis analysis of variance by ranks will be used. Baseline to 3 months data will be used to assess immediate intervention effects and to 9 month follow-up will be used to assess retention effects.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
40 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosis of heart failure with subsequent placement of a Medtronic® ICD or Cardiac Resynchronization Therapy (CRT) device at least 6 months prior to study enrollment
  • New York Heart Association Functional Class II to III symptoms on optimal medical therapy

排除标准

  • Any comorbid medical disease that would prevent safe participation in an individualized exercise program such as severe osteo-, rheumatoid-, and gout-related arthritis, unstable angina, exercise-induced arrhythmias, uncontrollable diabetes, or atrial fibrillation with rapid ventricular rate in the preceding 30 days.
  • Recent (<6 weeks) or planned (<6 months) major cardiovascular events or procedures
  • Current participation in a regular exercise training program
  • HF due to severe, uncorrected primary valvular disease, congenital heart disease, or obstructive cardiomyopathy
  • Adults unable to consent (e.g. cognitively impaired), pregnant women, and prisoners

结局指标

主要结局

Change in Medtronic Implanted Device Patient Activity Measure

时间窗: Change from baseline to 3 and 9 months

次要结局

  • Change in ActiGraph Daily Activity(Change from baseline to 3 and 9 months)
  • Change in Health Care Utilization(Change from baseline to 3 and 9 months)
  • Change in 30 Second Timed Chair Rise(Change from baseline to 3 and 9 months)
  • Change in Kansas City Cardiomyopathy Questionnaire(Change from baseline to 3 and 9 months)
  • Change in 9 Item Patient Health Questionnaire(Change from baseline to 3 and 9 months)
  • Change in Six-Minute Walk Test(Change from baseline to 3 and 9 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Michael J. Shoemaker

Associate Professor of Physical Therapy

Grand Valley State University

研究点 (2)

Loading locations...

相似试验

Interventions to Improve Daily Activity in Heart... | 临床试验